Sequential therapy in clarithromycin‐sensitive and ‐resistant Helicobacter pylori based on polymerase chain reaction molecular test
Sequential therapy in clarithromycin‐sensitive and ‐resistant Helicobacter pylori based on polymerase chain reaction molecular test
复制标题
DOI：
10.1111/j.1440-1746.2011.06660.x
复制
发表时间：
2011-05
影响因子：
4.1
通讯作者：
V. Mahachai;N. Sirimontaporn;S. Tumwasorn;D. Thong-ngam;R. Vilaichone
中科院分区：
文献类型：
--
作者：
V. Mahachai;N. Sirimontaporn;S. Tumwasorn;D. Thong-ngam;R. Vilaichone
背景和目的：本研究旨在确定泰国患者通过分子聚合酶链反应（PCR）检测确定的基因型克拉霉素耐药幽门螺杆菌群的10天序贯治疗的根除率。
Background and Aim: The present study was designed to determine the eradication rate of 10 day sequential therapy in genotypic clarithromycin‐resistant Helicobacter pylori group identified by molecular polymerase chain reaction (PCR) detection in Thai patients.